17 alpha-hydroxylase deficiency laboratory findings: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency}} {{CMG}}; {{AE}} {{Ammu}} ==Overview== Laboratory findings consistent with the diagnosis of...")
 
Line 18: Line 18:
* Decreased  testosterone
* Decreased  testosterone
* Decreased 17-hydroxylase corticosteroid
* Decreased 17-hydroxylase corticosteroid
* Decreased 17-ketosteroid
* Decreased urinary 17-ketosteroid
* Decreased estrogens
* Decreased estrogens
* Decreased  aldosterone
* Decreased  aldosterone
* Decreased  renin
* Decreased  renin
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 15:31, 9 February 2016

Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

17 alpha-hydroxylase deficiency laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on 17 alpha-hydroxylase deficiency laboratory findings

CDC on 17 alpha-hydroxylase deficiency laboratory findings

17 alpha-hydroxylase deficiency laboratory findings in the news

Blogs on 17 alpha-hydroxylase deficiency laboratory findings

Directions to Hospitals Treating Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency

Risk calculators and risk factors for 17 alpha-hydroxylase deficiency laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Laboratory findings consistent with the diagnosis of congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency include elevated 17α-hydroxyprogesterone, elevated androstenedione, elevated urinary 17-ketosteroids and decreased renin.

Laboratory Findings

  • Elevated levels of 11-deoxycorticosterone
  • Elevated levels of corticosterone
  • Elevated adrenocorticotropic hormone
  • Elevated follicle-stimulating hormone
  • Elevated luteinizing hormone
  • Decreased serum levels of 17-hydroxypregnenolone[1]
  • Decreased 17-hydroxyprogesterone
  • Decreased 11-deoxycortisol
  • Decreased cortisol
  • Decreased dehydroepiandrosterone
  • Decreased androstenedione
  • Decreased testosterone
  • Decreased 17-hydroxylase corticosteroid
  • Decreased urinary 17-ketosteroid
  • Decreased estrogens
  • Decreased aldosterone
  • Decreased renin

References

  1. Alqahtani, Mohammad A.; Shati, Ayed A.; Zou, Minjing; Alsuheel, Ali M.; Alhayani, Abdullah A.; Al-Qahtani, Saleh M.; Gilban, Hessa M.; Meyer, Brain F.; Shi, Yufei (2015). "A Novel Mutation in theCYP11B1Gene Causes Steroid 11β-Hydroxylase Deficient Congenital Adrenal Hyperplasia with Reversible Cardiomyopathy". International Journal of Endocrinology. 2015: 1–5. doi:10.1155/2015/595164. ISSN 1687-8337.

Template:WikiDoc Sources